Skip to content

Clinical Outcome of Multicatheter Brachytherapy APBI in breast-conserving Therapy (COMBAT)for breast cancer patients-A(adjuvant),-C(complications and cosmesis)

Clinical Outcome of Multicatheter Brachytherapy APBI in breast-conserving Therapy (COMBAT)for breast cancer patients-A(adjuvant),-C(complications and cosmesis) - Clinical Outcome of APBI in breast-conserving Therapy (COMBAT)for breast cancer patients-A(adjuvant),-C(complications and cosmesis)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000029907
Enrollment
850
Registered
2017-11-10
Start date
2017-11-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Sponsors

Tokyo-West Tokushukai Hospital Breast oncology center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients who satisfy all of the following criteria 1) Patients who are confirmed to be breast cancer histopathologically before breast-conserving surgery 2) Patients in clinical stage 0 to III 3) Patients with breast cancer whose maximum tumor size is 3 cm or less 4) Patients who have undergone or will receive breast conservation 5) female patient

Exclusion criteria

Exclusion criteria: Patients who conflict with one of the following 1) Patients with collagen disease 2) Pregnant or possibly having a possibility 3) Other patients judged inappropriate

Design outcomes

Primary

MeasureTime frame
Long term cosmesis

Countries

Japan

Contacts

Public ContactHiromi Fuchikami

Tokyo-West Tokushukai Hospital Breast oncology center

hiromi.fuchikami@tokushukai.jp042-500-4433

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026